## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and conclusions as presented in the abstract, without access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The abstract reports crystal structures of Haemophilus influenzae BirA in apo and holo (biotinyl-5'-AMP bound) forms, describes a three-domain architecture (N-terminal DNA binding, central catalytic, C-terminal SH3-like), observes ordering of the biotin-binding loop upon ligand binding that promotes dimerization, notes conservation of ligand-binding residues across homologs, and uses AlphaFold2 to model a heterodimeric complex with biotin carboxyl carrier protein. The authors suggest these findings support BirA as a target for novel antibiotics.
- **Visible evidence base** Abstract text only; no structural coordinates, crystallographic statistics, sequence alignments, or modeling details are provided
- **Missing materials affecting confidence** Full manuscript, crystallographic data and refinement statistics, structural figures, sequence alignment data, AlphaFold2 modeling parameters and confidence metrics, experimental validation of functional claims, and any comparative analysis details

## Reviewer
- **Overall assessment** The abstract presents a structurally focused study with potentially useful insights into a bifunctional bacterial protein. The core crystallographic findings are plausible and align with prior BirA literature, but the abstract alone does not provide sufficient evidence to evaluate the technical quality of the structure determination, the robustness of the conformational change claim, or the validity of the AlphaFold2-based interaction model. The antibiotic target framing is speculative and not supported by data presented in the abstract.
- **Who would be interested in the results, and why** Structural biologists studying biotin-dependent enzymes and transcriptional regulators would find the new BirA structures of interest for comparative analysis. Microbiologists investigating bacterial biotin metabolism and potential antimicrobial targets may also be interested, though the translational implications are not yet substantiated. The work could serve as a reference for structure-function studies of class II BirA proteins.
- **Major strengths** The study addresses a protein with dual functional roles, which adds biological relevance beyond a routine structure determination. The comparison of apo and holo forms to capture a ligand-induced conformational change is a sound experimental design. The use of AlphaFold2 to generate testable hypotheses about protein-protein interactions is a modern and appropriate complementary approach.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1 (structural quality), R1-M2 (dimerization claim), R1-M3 (AlphaFold2 model validity)
- **Assessment against Nature-style criteria** Originality: moderate, as BirA structures from other organisms exist, but the Haemophilus influenzae form and its apo/holo comparison add incremental novelty. Scientific importance: limited at this stage, as the abstract does not establish functional consequences beyond structural observation. Interdisciplinary readership: narrow, primarily structural biology and bacterial metabolism specialists. Technical soundness: cannot be assessed from the abstract alone, as no crystallographic or modeling quality metrics are provided. Readability for nonspecialists: the abstract is clear and accessible, though some domain terminology assumes background knowledge.

## Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** The abstract claims crystal structures of Hin BirA in apo and holo forms were determined.
- **Evidence pointer** Abstract, structural results section (location not provided)
- **Concern** No crystallographic quality indicators are reported, including resolution, R-factors, or validation statistics. Without these, the reliability of the structural models cannot be evaluated.
- **Why it matters** Structural claims are only as credible as the underlying data quality. Poor resolution or refinement issues could undermine the interpretation of the biotin-binding loop ordering and domain architecture.
- **Resolution test** Provide resolution, R-work/R-free, Ramachandran statistics, and coordinate error estimates for both structures in the full manuscript.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Claim support
- **Claim pointer** The abstract states that biotin-binding loop ordering upon biotinyl-5'-AMP binding promotes protein dimerization.
- **Evidence pointer** Abstract, structural comparison section (location not provided)
- **Concern** The causal link between loop ordering and dimerization is asserted without supporting evidence. The abstract does not indicate whether dimerization is observed in solution, whether the dimer interface is characterized, or whether the apo form is monomeric.
- **Why it matters** This is a central mechanistic claim of the study. If dimerization is only inferred from crystal packing or a single holo structure, the conclusion may be overstated.
- **Resolution test** Include solution-based oligomerization data (e.g., SEC-MALS, AUC) and a clear description of the dimer interface with supporting figures in the full manuscript.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** The abstract claims AlphaFold2 was used to model a potential heterodimeric interaction between Hin BirA and biotin carboxyl carrier protein, providing insights into the structural basis for biotinylation.
- **Evidence pointer** Abstract, modeling section (location not provided)
- **Concern** No details are given on the AlphaFold2 protocol, including whether the complex was modeled directly or via docking, what confidence metrics were obtained (pLDDT, PAE), or whether the predicted interface is consistent with known BirA-BCCP interactions.
- **Why it matters** AlphaFold2 predictions are hypothesis-generating, not experimental validation. Without confidence metrics or experimental corroboration, the interaction model cannot be considered established.
- **Resolution test** Report AlphaFold2 confidence scores, provide a figure of the predicted complex with interface residues, and discuss agreement with any existing experimental data on BirA-BCCP interactions.

## Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Domain nomenclature
- **Evidence pointer** Abstract, structural description (location not provided)
- **Issue** The abstract states Hin BirA is a class II BirA with three domains but does not explain what distinguishes class II from other classes.
- **Required correction** Add a brief contextual statement defining class II BirA or cite the classification scheme in the full manuscript.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Claim support
- **Affected element** Conservation claim
- **Evidence pointer** Abstract, comparative studies section (location not provided)
- **Issue** The claim that residues responsible for biotinyl-5'-AMP binding are highly conserved is made without specifying which organisms were compared or the extent of conservation.
- **Required correction** Provide a sequence alignment figure or a table listing the compared species and the conservation percentages in the full manuscript.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Scope
- **Affected element** Translational framing
- **Evidence pointer** Abstract, concluding statement (location not provided)
- **Issue** The suggestion that Hin BirA is a potential target for novel antibiotics is not supported by any data in the abstract, such as selectivity over human biotin ligases or essentiality evidence.
- **Required correction** Either remove the antibiotic target statement or add a brief justification with appropriate references in the discussion.

## Risk / unsupported claims
- The claim that biotin-binding loop ordering promotes dimerization is unsupported without solution-phase oligomerization data.
- The AlphaFold2-based heterodimeric interaction model is presented as providing insights, but no confidence metrics or experimental validation are reported, making the claim unverifiable from the abstract.
- The antibiotic target suggestion is speculative and not supported by any data presented.
- The conservation of ligand-binding residues is asserted without showing the comparative dataset.
- The overall functional significance of the structural findings for biotinylation is not established beyond the modeling prediction.